Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
2.160
-0.130 (-5.68%)
At close: Jan 14, 2025, 4:00 PM
2.170
+0.010 (0.46%)
Pre-market: Jan 15, 2025, 8:45 AM EST
Outlook Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 14, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 54 | 126 | 58 | 276 | 380 | 92 | |
| Market Cap Growth | 119.63% | 119.63% | -79.15% | -27.49% | 315.51% | 117.68% | |
| Enterprise Value | 69 | 127 | 59 | 260 | 372 | 73 | |
| Last Close Price | 2.16 | 5.34 | 4.42 | 24.40 | 43.40 | 14.40 | |
| PB Ratio | -1.73 | -1.73 | -3.98 | 31.58 | 82.58 | 32.40 | |
| P/TBV Ratio | - | - | - | 31.58 | 82.58 | 32.40 | |
| Debt / Equity Ratio | -0.41 | -0.41 | -2.46 | 1.25 | 2.58 | 1.71 | |
| Quick Ratio | 0.35 | 0.35 | 0.50 | 0.88 | 2.14 | 0.84 | |
| Current Ratio | 0.64 | 0.64 | 0.66 | 1.39 | 3.19 | 1.13 | |
| Return on Equity (ROE) | - | - | - | -989.99% | -1430.33% | - | |
| Return on Assets (ROA) | -146.64% | -146.64% | -109.17% | -153.56% | -151.98% | -123.12% | |
| Return on Capital (ROIC) | - | - | -162.72% | -217.76% | -267.59% | -383.73% | |
| Earnings Yield | -140.10% | -59.66% | -102.55% | -23.94% | -13.97% | -38.48% | |
| FCF Yield | -127.88% | -54.46% | -74.72% | -20.54% | -14.26% | -34.72% | |
| Buyback Yield / Dilution | -48.29% | -48.29% | -17.96% | -38.91% | -110.43% | -298.84% | |
| Total Shareholder Return | -48.29% | -48.29% | -17.96% | -38.91% | -110.43% | -298.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.